Novo Nordisk A/S (NOVO-B.CO)
Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
As of 11:16AM CEST. Market open.
| Previous close | 866.80 |
| Open | 874.50 |
| Bid | 870.10 x 0 |
| Ask | 870.40 x 0 |
| Day's range | 867.30 - 876.40 |
| 52-week range | 504.40 - 932.00 |
| Volume | |
| Avg. volume | 2,754,971 |
| Market cap | 3.882T |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | 46.68 |
| EPS (TTM) | 18.64 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | 12.80 (1.48%) |
| Ex-dividend date | 22 Mar 2024 |
| 1y target est | 905.68 |
Investor's Business DailyIs Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
ZacksZacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.
ZacksNovo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why
In the latest trading session, Novo Nordisk (NVO) closed at $126.16, marking a -1.93% move from the previous day.
© 2024 Yahoo. All rights reserved.